1. The COVID-19 Pandemic in a Hispanic Population: A Primary Care Perspective.
- Author
-
Owens CD, Pertuz GM, Sanchez JC, Ayala J, Pimentel LH, Lamb C, Lopez Mayo YE, and Yunez AL
- Subjects
- Hispanic or Latino, Humans, Pandemics, Primary Health Care, Retrospective Studies, SARS-CoV-2, COVID-19 epidemiology
- Abstract
Introduction: The COVID-19 global pandemic has affected all ethnic and minority groups although not equally. The goals of the present study are twofold: describe the diverse COVID-19-related care needs Hispanic patients presenting to a primary care facility and the symptom clusters and socioeconomic factors that may impact their wellbeing., Methods: This is a retrospective cohort of Hispanic patients in an outpatient clinic serving an urban lower socioeconomic demographic, between May 9 and July 31, 2020. COVID-19 infection was confirmed by polymerase chain reaction or rapid antibody test. Student's t-test was used for means and the chi
2 was used for comparisons of proportions., Results: A total of 6616 patients visited Alivio, 409 were triaged to a containment area, and 378 were tested for COVID-19; 230 with, 148 without symptoms. Of those tested, 161(42.6%) were positive, representing 2.4% of total patients seen. Age, temperature, and pulse rate were all significantly higher in patients with symptoms compared with those without. Symptoms were grouped into 5 clusters: constitutional, n = 143(62%), respiratory, n = 136 (59%), and somatic, n = 97(42%) were most common. No single cluster was particularly diagnostic of COVID-19, although those with symptoms in multiple clusters were more likely to test positive, P < .001. The majority worked in essential jobs, were uninsured, and had more than half had prolonged symptoms., Conclusions: Hispanic patients have diverse reasons for seeking health care and for testing in a pandemic. COVID-19 is a syndromic disease as evidenced from the clustering of symptoms. Essential workers and uninsured health status may lead to more prolonged disease course., Competing Interests: Conflicts of interest: There are no conflicts or competing interests to declare. Christopher Lamb, PhD, has worked with the manufacturers of SARS-CoV-2 tests for Emergency Use Authorization submissions to the US FDA., (© Copyright 2022 by the American Board of Family Medicine.)- Published
- 2022
- Full Text
- View/download PDF